John H. Krystal
9Patents
4h-index
9Co-inventors
50Inventor score
Filing activity: May 7, 1992 → Oct 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8785500B2 | Intranasal administration of ketamine to treat depression | Human Necessities | 42 | Active |
| US5447948A | Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia | Human Necessities | 18 | Expired |
| US9592207B2 | Intranasal administration of ketamine to treat depression | Human Necessities | 12 | Active |
| US9539220B2 | Methods for treating suicidal ideation | Human Necessities | 4 | Active |
| US10052318B2 | Glutamate agents in the treatment of mental disorders | Electricity | 0 | Active |
| US11793794B2 | Combination therapy for treating or preventing depression or other mood diseases | Human Necessities | 0 | Active |
| US8778979B2 | Glutamate agents in the treatment of mental disorders | Electricity | 0 | Active |
| US12090145B2 | Combination therapy for treating or preventing depression or other mood diseases | Human Necessities | 0 | Active |
| US11554117B2 | Glutamate agents in the treatment of mental disorders | Electricity | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.